Showing 2679 results for "amyotrophic lateral sclerosis (ALS)"

Stress Granules May Be Key to ALS and Related Diseases

Scientists at St. Jude Children’s Research Hospital may have unlocked the key to understanding amyotrophic lateral sclerosis (ALS) and other similar diseases of the nervous system. The study, titled “Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization,” appeared in the September…

Synapse Biomedical To Present Data on NeuRx Diaphragm Pacing System In ALS Patients

Synapse Biomedical Inc., a company that commercializes the NeuRx Diaphragm Pacing System (DPS), has recently announced it will be presenting data on the company’s Post Approval Study (PAS), a multi-center trial that demonstrated DPS’s safety and survival benefit, during the 26th International Symposium on ALS/MND. Data will be presented by Dr. Robert Miller, Principal Investigator of the…

Review On The Link Between Autophagy And ALS

Researchers at Università degli Studi di Milano in Italy recently published in the journal Cells a review regarding the link between autophagy and amyotrophic lateral sclerosis (ALS). The study is entitled “Autophagy and Neurodegeneration: Insights from a Cultured Cell Model of ALS”. Autophagy…

Project ALS Reports All Donations From 2014 Ice Bucket Challenge Have Been Spent On Research

Social media sensation The Ice Bucket Challenge (an event that raised awareness for ALS) is celebrating its one-year anniversary, with the Project A.L.S. reporting it has now spent 100 percent of the donations raised during the 6-week challenge period on several research projects that have already revealed promising results. Amyotrophic lateral sclerosis (ALS) is a fatal and progressive…

Antioxidant MitoQ Shown As A Promising Therapy for ALS

A study led by researchers at The Center of Free Radical and Biomedical Research at Universidad de la Republica in Uruguay revealed that antioxidant therapies like MitoQ are a promising treatment strategy for amyotrophic lateral sclerosis (ALS). The study was published in the journal Free Radical Biology…

ALS Association Grants $1.5M to Researcher Robert G. Miller

The ALS Association has recently awarded a $1.5 million grant to investigator Robert G. Miller, MD, to be invested in the study of a potential treatment for amyotrophic lateral sclerosis (ALS), called NP001. Dr. Miller is studying Neuraltus Pharmaceuticals’ investigational therapy which will now enter a phase 2 clinical trial.